חזרה לתוצאות החיפוש

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Metastatic Solid Tumor · Recurrent Solid Tumor · Advanced Solid Tumor · Urinary Bladder Neoplasm · Triple Negative Breast Cancer · Non-small Cell Lung Cancer · Esophageal Cancer · Pancreatic Cancer · Ovarian Cancer · Cervical Cancer · Head and Neck Squamous Cell Carcinoma · Prostate Cancer · Renal Pelvis Cancer · Bladder Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • City of Hope National Medical Center, Duarte, California, United States

  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles, California, United States

  • Sarah Cannon Research Institute at HealthOne, Denver, Colorado, United States

  • Florida Cancer Specialists and Research Institute, St. Petersburg, Florida, United States

  • University of Chicago Hospital, Chicago, Illinois, United States

  • IU Simon Cancer Center, Indianapolis, Indiana, United States

  • Massachusetts General Hospital, Boston, Massachusetts, United States

  • START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids, Michigan, United States

  • Washington University School of Medicine in St. Louis, St Louis, Missouri, United States

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • Columbia University Irving Medical Center, New York, New York, United States

  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

  • University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

  • Sarah Cannon Research Institute, Nashville, Tennessee, United States

  • University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • South Texas Accelerated Research Therapeutics (START), San Antonio, Texas, United States

  • University of Utah - Huntsman Cancer Institute, Salt Lake City, Utah, United States

  • START Mountain Region, West Valley City, Utah, United States

  • St Vincent's Hospital, Darlinghurst, Australia

  • Linear Clinical Research, Nedlands, Australia

  • Beijing Cancer hospital, Beijing, China

  • Sun Yat-sen University Cancer Center, Guangzhou, China

  • Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

  • Institut Gustave Roussy (Igr), Villejuif, France

  • National Cancer Center Hospital, Chūōku, Japan

  • National Cancer Center Hospital East, Kashiwa, Chiba, Japan

  • The Cancer Institute Hospital of JFCR, Kōtō City, Japan

  • Aichi Cancer Center Hospital, Nagoya, Japan

  • Asan Medical Center, Seoul, South Korea

  • Catalan Institute of Oncology Duran i Reynals Hospital, Barcelona, Spain

  • Hospital Universitario 12 de Octubre, Madrid, Spain

  • Hospital Madrid Norte Sanchinarro, Madrid, Spain

  • Hospital Universitario Virgen Del Rocio, Seville, Spain

  • St Bartholomew's Hospital, London, United Kingdom

  • The Christie NHS Foundation Trust, Manchester, United Kingdom

מובילי המחקר

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)